Curative Biotechnology Inc SEC filings CUBT
Curative Biotechnology Inc has 51 filings in SEC EDGAR's recent list, going back to May 9, 2007. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| RW | Filing | Dec 22, 2025 | — |
| S-1/A | Amended registration statement | Aug 1, 2025 | — |
| S-1 | Registration statement | May 6, 2024 | — |
| RW | Filing | Feb 1, 2024 | — |
| S-1/A | Amended registration statement | Jan 25, 2023 | — |
| D | Filing | Jan 18, 2023 | — |
| S-1/A | Amended registration statement | Jan 13, 2023 | — |
| S-1/A | Amended registration statement | Jan 9, 2023 | — |
| 8-A12B/A | Filing | Dec 1, 2022 | — |
| S-1/A | Amended registration statement | Nov 30, 2022 | — |
| S-1/A | Amended registration statement | Nov 16, 2022 | — |
| S-1 | Registration statement | Nov 7, 2022 | — |
| RW | Filing | Oct 31, 2022 | — |
| EFFECT | Filing | Oct 13, 2022 | — |
| CORRESP | Letter to the SEC | Oct 11, 2022 | — |
| CERT | Nyse american certification | Oct 5, 2022 | — |
| 8-A12B | Filing | Oct 5, 2022 | — |
| CORRESP | Letter to the SEC | Sep 30, 2022 | — |
| S-1/A | Amended registration statement | Sep 30, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 29, 2022 | — |
| S-1/A | Amended registration statement | Sep 28, 2022 | — |
| CORRESP | Letter to the SEC | Sep 9, 2022 | — |
| S-1/A | Amended registration statement | Sep 9, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 8, 2022 | — |
| S-1/A | Amended registration statement | Sep 1, 2022 | — |
| CORRESP | Letter to the SEC | Aug 10, 2022 | — |
| S-1/A | Amended registration statement | Aug 10, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 8, 2022 | — |
| S-1/A | Amended registration statement | Aug 1, 2022 | — |
| S-1/A | Amended registration statement | Jul 8, 2022 | — |
| CORRESP | Letter to the SEC | Jul 8, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 7, 2022 | — |
| S-1/A | Amended registration statement | Jun 29, 2022 | — |
| CORRESP | Letter to the SEC | Apr 25, 2022 | — |
| S-1/A | Amended registration statement | Apr 25, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 21, 2022 | — |
| CORRESP | Letter to the SEC | Apr 15, 2022 | — |
| S-1 | Registration statement | Apr 15, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 5, 2022 | — |
| DRSLTR | Filing | Mar 28, 2022 | — |
| DRS/A | Filing | Mar 25, 2022 | — |
| D | Filing | Mar 21, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 21, 2022 | — |
| DRSLTR | Filing | Jan 10, 2022 | — |
| DRS/A | Filing | Jan 10, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 21, 2021 | — |
| DRS | Filing | Nov 24, 2021 | — |
| D | Filing | Oct 13, 2009 | — |
| REGDEX | Auto-generated paper document | Apr 23, 2008 | — |
| 8-K12B | Current report on form 8-k | Feb 14, 2008 | Feb 14, 2008 |
| REGDEX/A | Auto-generated paper document | May 9, 2007 | — |
Showing 51 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CUBT (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- FL
- Headquarters
- Boca Raton, FL
- SEC CIK
- 1400271
- Former names
- Connectyx Technologies Corp (until Oct 13, 2009)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.